Connecting Care: Outpatient Treatment of COVID-19 With Neutralizing Monoclonal Antibodies
Host: Jennifer Caudle, DO
Guest: Andrew D. Badley, MD, FRCP(C), FACP, FIDSA
Guest: Chad Worz, PharmD, BCGP, FASCP
The United States is one of the hardest hit countries with SARS-CoV-2 with many more deaths expected in early 2021. Outpatient infusion treatment with neutralizing monoclonal antibodies (nAbs) is an important treatment option for some patients. This 30-minute ReachMD program helps you recognize appropriate patients for nAb-therapy and presents the most recent evidence on ambulatory options. Get expert perspectives from a physician and pharmacist as they present compelling case studies. This broadcast replay includes a pre-read summarizing key clinical trial information.